Hanlin Gao - 30 Apr 2025 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role
Chief Scientific Officer
Signature
/s/ Paul Kim as Attorney-in-Fact
Issuer symbol
FLGT
Transactions as of
30 Apr 2025
Transactions value $
-$1,371
Form type
4
Filing time
02 May 2025, 16:53:04 UTC
Previous filing
29 Apr 2025
Next filing
28 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gao Hanlin Chief Scientific Officer C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE /s/ Paul Kim as Attorney-in-Fact 02 May 2025 0001684532

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLGT Common Stock Tax liability -$1.37K -79 -0.01% $17.35 963K 30 Apr 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on April 30, 2021, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on May 3, 2021.